FIELD: medicine. SUBSTANCE: method involves determining spectral density of power in the range of very high frequencies with hyperergic, normergic and hypoergic types of response being detected. Hyperergic response type being found and spectral density of power being greater than 130 ms2, Dalargin is intravenously administered at a single bolus dose of 1-2 mg/kg of body mass. Hypoergic response type being found and spectral density of power being less than 25 ms2, Neoton is administered as infusion at a single bolus dose of 60 mg/kg of body mass. EFFECT: enhanced effectiveness of treatment. 3 tbl
Authors
Dates
2002-04-27—Published
1998-12-15—Filed